Literature DB >> 30116394

Effects of CoCl2-simulated hypoxia on the expression levels of matrix metalloproteinases in renal adenocarcinoma cells and renal tubular epithelial cells.

Xiaoyi Zhang1, Ling Chen1.   

Abstract

Renal cell carcinoma (RCC) and chronic kidney disease (CKD) are associated with hypoxia, but the effects of hypoxia on the process of angiogenesis in the two diseases are dramatically different. Some of matrix metalloproteinases (MMPs), such as MMP2 and MMP9, may have a role because they represent the most prominent family of proteinases associated with angiogenesis. In the present study, the differential response of human renal cell cancer cells (786-0), human renal tubular epithelial cells (HK-2) and human microvascular endothelial cells (HMEC-1) to hypoxia with regards to the expression of MMP2, MMP9, MMP14, TIMP2, RECK was investigated. Cobalt chloride (CoCl2) treatment was used to simulate the hypoxia environment in RCC and CKD. The expression levels of HIF-1α, RECK, MMP2, MMP9, MMP14 and TIMP2 in HK2, 786-0 and HMEC-1 cells were determined by western blot analysis after incubation with varying concentrations of CoCl2 for 24 h. It was indicated that the effects of hypoxia on the endogenous expression of RECK and MMP2 differed depending on the considered cell type. Notably, the RECK expression was significantly decreased in 786-0 cells under hypoxia, whereas this expression was slightly increased in HK2 and HMEC-1 cells. Furthermore, the MMP2 expression was significantly increased in HMEC-1 cells under hypoxia, whereas the expression was slightly decreased in HK2 and 786-0 cells. These results demonstrate that 786-0, HK2 and HMEC-1 cells respond differently under hypoxic conditions. Furthermore, MMP2 and RECK may serve divergent roles in HK2 and HMEC-1 cells under hypoxic conditions.

Entities:  

Keywords:  angiogenesis; chronic kidney disease; cobalt chloride; matrix metalloproteinases; renal cell carcinoma

Year:  2018        PMID: 30116394      PMCID: PMC6090308          DOI: 10.3892/etm.2018.6337

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  20 in total

1.  Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells.

Authors:  Katsuya Ando; Toshiyuki Ishibashi; Hiroshi Ohkawara; Nobutaka Inoue; Koichi Sugimoto; Hironori Uekita; Chengjun Hu; Yasuo Okamoto; Yoh Takuwa; Yasuchika Takeishi
Journal:  J Atheroscler Thromb       Date:  2011-06-01       Impact factor: 4.928

2.  Morphometric and visual evaluation of fibrosis in renal biopsies.

Authors:  Alton B Farris; Catherine D Adams; Nicole Brousaides; Patricia A Della Pelle; A Bernard Collins; Ellie Moradi; R Neal Smith; Paul C Grimm; Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

3.  MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.

Authors:  So-Young Lee; Markus Hörbelt; Henry E Mang; Nicole L Knipe; Robert L Bacallao; Yoshikazu Sado; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-30

4.  Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs.

Authors:  F Loayza-Puch; Y Yoshida; T Matsuzaki; C Takahashi; H Kitayama; M Noda
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

5.  Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation.

Authors:  Yaara Ben-Yosef; Nitza Lahat; Sarah Shapiro; Haim Bitterman; Ariel Miller
Journal:  Circ Res       Date:  2002-04-19       Impact factor: 17.367

6.  Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner.

Authors:  A Miyoshi; Y Kitajima; T Ide; K Ohtaka; H Nagasawa; Y Uto; H Hori; K Miyazaki
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

7.  Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.

Authors:  Hao Lin; Jin-cheng Pan; Fa-ming Zhang; Bin Huang; Xu Chen; Jin-tao Zhuang; Hua Wang; Cheng-qiang Mo; Dao-hu Wang; Shao-peng Qiu
Journal:  Urol Oncol       Date:  2015-01-21       Impact factor: 3.498

8.  Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Authors:  Yuki Hamano; Michael Zeisberg; Hikaru Sugimoto; Julie C Lively; Yohei Maeshima; Changqing Yang; Richard O Hynes; Zena Werb; Akulapalli Sudhakar; Raghu Kalluri
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

9.  The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9.

Authors:  Jianzhong Hu; Shuangfei Ni; Yong Cao; Tao Zhang; Tianding Wu; Xianzhen Yin; Ye Lang; Hongbin Lu
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 10.  Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.

Authors:  Qishan Chen; Min Jin; Feng Yang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Mediators Inflamm       Date:  2013-06-12       Impact factor: 4.711

View more
  2 in total

1.  Alterations of RNA Modification in Mouse Germ Cell-2 Spermatids Under Hypoxic Stress.

Authors:  Tong He; Huanping Guo; Lin Xia; Xipeng Shen; Yun Huang; Xiao Wu; Xuelin Jiang; Yinying Xu; Yi Tan; Yunfang Zhang; Dongmei Tan
Journal:  Front Mol Biosci       Date:  2022-06-14

2.  Regenerative Activities of ROS-Modulating Trace Metals in Subcutaneously Implanted Biodegradable Cryogel.

Authors:  Abdulla A Yergeshov; Mohamed Zoughaib; Rezeda A Ishkaeva; Irina N Savina; Timur I Abdullin
Journal:  Gels       Date:  2022-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.